ArticleCancer discovery2022

Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer.

Yong Gu Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.